|
Verona Pharma starts asthma drug Phase II trial
Pharmaceutical Business Review Verona Pharma has started a Phase II trial of its respiratory drug RPL554 to determine if the drug has sustained bronchodilator actions, and is safe when given daily to patients who are suffering from mild asthma. The company has also treated first … Verona Pharma starts new trial of lead drug |
View full post on asthma – Google News